171 related articles for article (PubMed ID: 10459402)
1. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos.
Figueras G; Pérez V; San Martino O; Alvarez E; Artigas F
Biol Psychiatry; 1999 Aug; 46(4):518-24. PubMed ID: 10459402
[TBL] [Abstract][Full Text] [Related]
2. The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression.
Mück-Seler D; Pivac N; Sagud M; Jakovljević M; Mihaljević-Peles A
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1235-43. PubMed ID: 12502009
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression.
Goodnick PJ; Kumar AM
Biol Psychiatry; 2000 May; 47(9):846-7. PubMed ID: 10819459
[No Abstract] [Full Text] [Related]
4. Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments.
Pérez V; Bel N; Celada P; Ortiz J; Alvarez E; Artigas F
J Clin Psychopharmacol; 1998 Jun; 18(3):222-30. PubMed ID: 9617981
[TBL] [Abstract][Full Text] [Related]
5. A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment.
Sagud M; Nikolac Perkovic M; Vuksan-Cusa B; Maravic A; Svob Strac D; Mihaljevic Peles A; Zivkovic M; Kusevic Z; Pivac N
Psychopharmacology (Berl); 2016 Sep; 233(17):3259-67. PubMed ID: 27356518
[TBL] [Abstract][Full Text] [Related]
6. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
[TBL] [Abstract][Full Text] [Related]
7. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders.
Yasui-Furukori N; Nakagami T; Kaneda A; Inoue Y; Suzuki A; Otani K; Kaneko S
Hum Psychopharmacol; 2011 Dec; 26(8):602-8. PubMed ID: 22102561
[TBL] [Abstract][Full Text] [Related]
9. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.
Li X; Fan Y; Xiao S; Peng S; Dong X; Zheng X; Liu CC; Li H; Xiao Z
J Affect Disord; 2015 Nov; 187():84-90. PubMed ID: 26321259
[TBL] [Abstract][Full Text] [Related]
10. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
[TBL] [Abstract][Full Text] [Related]
11. Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine.
Munno D; Sterpone S; Fania S; Cappellin F; Mengozzi G; Saroldi M; Bechon E; Zullo G
Panminerva Med; 2013 Dec; 55(4):377-84. PubMed ID: 24434345
[TBL] [Abstract][Full Text] [Related]
12. Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.
Aldosary F; Norris S; Tremblay P; James JS; Ritchie JC; Blier P
Int J Neuropsychopharmacol; 2022 Apr; 25(4):283-292. PubMed ID: 34958348
[TBL] [Abstract][Full Text] [Related]
13. Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study.
Van Holten TC; Roest M; Riphagen J; Jansen C; Naarding P; Adriaansen HJ; De Groot PG; Remijn JA
J Thromb Haemost; 2012 Jun; 10(6):1177-9. PubMed ID: 22429872
[No Abstract] [Full Text] [Related]
14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine.
Gilmor ML; Owens MJ; Nemeroff CB
Am J Psychiatry; 2002 Oct; 159(10):1702-10. PubMed ID: 12359676
[TBL] [Abstract][Full Text] [Related]
16. Triiodothyronine addition to paroxetine in the treatment of major depressive disorder.
Appelhof BC; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Huyser J; Schene AH; Tijssen JG; Wiersinga WM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6271-6. PubMed ID: 15579788
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine in major depression: correlating plasma concentrations and clinical response.
Normann C; Hörn M; Hummel B; Grunze H; Walden J
Pharmacopsychiatry; 2004 May; 37(3):123-6. PubMed ID: 15138896
[TBL] [Abstract][Full Text] [Related]
18. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.
Messa C; Colombo C; Moresco RM; Gobbo C; Galli L; Lucignani G; Gilardi MC; Rizzo G; Smeraldi E; Zanardi R; Artigas F; Fazio F
Psychopharmacology (Berl); 2003 Apr; 167(1):72-8. PubMed ID: 12632246
[TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
[TBL] [Abstract][Full Text] [Related]
20. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
Musselman DL; Marzec UM; Manatunga A; Penna S; Reemsnyder A; Knight BT; Baron A; Hanson SR; Nemeroff CB
Arch Gen Psychiatry; 2000 Sep; 57(9):875-82. PubMed ID: 10986551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
